Discontinued — last reported Q4 '20
Medline, Inc. Debt Issuance Cost Amortization decreased by 26.7% to $11.00M in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 26.7%, from $15.00M to $11.00M.
An increase suggests higher historical debt issuance activity or more complex financing structures, while a decrease may indicate maturing debt or lower refinancing activity.
This represents the non-cash expense recognized over the life of a debt instrument related to the initial costs incurred...
Standard across all capital-intensive firms with significant long-term debt; peers often report this within the 'Amortization of debt discount' line item.
amortization_of_debt_issuance_costs| Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Value | $20.00M | $20.00M | $20.00M | $20.00M | $14.25M | $14.25M | $14.25M | $14.25M | $15.00M | $11.00M |
| QoQ Change | — | +0.0% | +0.0% | +0.0% | -28.7% | +0.0% | +0.0% | +0.0% | +5.3% | -26.7% |
| YoY Change | — | — | — | — | -28.7% | -28.7% | -28.7% | -28.7% | +5.3% | -26.7% |